Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen-progestin

Canadian Journal of Physiology and Pharmacology
Tolulope E OmolekuloL A Olatunji

Abstract

Elevated circulating uric acid has been postulated to play an important pathophysiological role in estrogen-progestin combined oral contraceptive (COC)-induced hypertension and endothelial dysfunction. We hypothesized that disruption of glucoregulation and liver triglyceride (TG) accumulation induced by COC use would be abated by valproic acid (VPA) treatment through suppression of adenosine deaminase (ADA) and xanthine oxidase (XO) activities. Female Wistar rats aged 9-10 weeks were treated with a combination of estrogen-progestin COC steroids (1.0 μg ethinylestradiol and 5.0 μg levonorgestrel; p.o.) with or without VPA (100.0 mg/kg; p.o.) daily for 6 weeks. The result shows that the disrupted glucoregulation and associated elevated hepatic ADA activity, plasma and hepatic XO activity, uric acid (UA), TG/HDL-cholesterol, total cholesterol, and malondialdehyde induced by COC treatment were attenuated by VPA treatment. However, VPA did not have any effect on plasma aldosterone, corticosterone, ADA, circulating and hepatic free fatty acid. Our results demonstrate that suppression of plasma and hepatic XO activities, along with hepatic ADA activity and UA by VPA treatment, protects against disrupted glucoregulation and increased l...Continue Reading

References

Oct 11, 1992·American Journal of Obstetrics and Gynecology·R M Krauss, R T Burkman
Jun 1, 1991·Biochemical Pharmacology·J G Niedzwicki, D R Abernethy
Oct 1, 1995·Acta Paediatrica Japonica; Overseas Edition·H NoguchiG Takada
Jul 21, 2000·The Journal of Clinical Investigation·G I Shulman
Aug 22, 2000·Archives of Disease in Childhood. Fetal and Neonatal Edition·F EbbesenM Rix
Oct 24, 2000·Trends in Endocrinology and Metabolism : TEM·R N Bergman, M Ader
Sep 5, 2002·Free Radical Biology & Medicine·Roger Harrison
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·George A Bray
Aug 28, 2004·Clinics in Liver Disease·Arthur J McCullough
Oct 20, 2005·American Journal of Physiology. Renal Physiology·Takahiko NakagawaRichard J Johnson
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Jun 1, 1942·The Biochemical Journal·T Brady
Sep 14, 2006·The Journal of Clinical Endocrinology and Metabolism·Kristina M Utzschneider, Steven E Kahn
Sep 19, 2006·Metabolism: Clinical and Experimental·Sofia G TsouliMoses S Elisaf
May 30, 2007·Archives of Internal Medicine·Peter W F WilsonRalph B D'Agostino
Jan 8, 2008·Lancet·M D Cappellini, G Fiorelli
Feb 2, 2008·World Journal of Gastroenterology : WJG·Madhusudana Girija Sanal
Mar 22, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Jean-Pierre DesprésPaul Poirier
Oct 9, 2008·American Journal of Physiology. Endocrinology and Metabolism·David H Wasserman
Oct 24, 2008·The New England Journal of Medicine·Daniel I FeigRichard J Johnson
Dec 11, 2008·Metabolic Syndrome and Related Disorders·Luis E Simental-MendíaFernando Guerrero-Romero
Oct 20, 2009·The Journal of Clinical Endocrinology and Metabolism·Mark S Cooper, Paul M Stewart
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Nov 28, 2009·Free Radical Biology & Medicine·Eric E KelleyMargaret M Tarpey
May 13, 2010·Digestive Diseases·Hannele Yki-Järvinen
Jun 26, 2010·Diabetes/metabolism Research and Reviews·Hong WangBarbara V Howard
Aug 28, 2010·International Journal of Epidemiology·Stephen O CrawfordJeffery Hunter Young
Oct 6, 2010·The American Journal of Medicine·Vidula BholeHyon Choi
Apr 8, 2011·Molecular Medicine Reports·Yugang WangXinmin Wang
Dec 17, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Shamshad J SherajeeHirofumi Hitomi
Jan 18, 2012·The Biochemical Journal·Peter J RoachVincent S Tagliabracci
Dec 6, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sung Keun ParkJae-Hong Ryoo
Dec 15, 2012·Endocrine Reviews·K H WilliamsS M Twigg
May 15, 2013·Annals of Medicine·Giovanni Tarantino, Domenico Capone
May 22, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Wilasinee SuwanjangBanthit Chetsawang
Jul 3, 2013·American Journal of Epidemiology·Kunihiro MatsushitaJ Hunter Young

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.